Tobramycin is an anti-infective used to treat serious bacterial infections, including meningitis and infections of the blood, abdomen, lungs, bone and urinary tract.
Claris currently has 14 drug approvals, with 24 pending. The company expects more market approvals later this year.
More articles on supply chain:
4 latest FDA approvals
Pfizer agrees to acknowledge addiction risks in opioid marketing
FDA approves safety device that prevents needle sticks
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
